Drug class in one race
VEGF-A drugs for Age-Related Macular Degeneration
12 tracked VEGF-A drugs in the Age-Related Macular Degeneration race. The class explanation lives on the VEGF-A page; the full indication pipeline across every mechanism is on the Age-Related Macular Degeneration page.
4 approved / phase 47 Phase 31 Phase 2/3
Head-to-head evidence: ABBV-RGX-314 vs Aflibercept · ABBV-RGX-314 vs Brolucizumab-Dbll · ABBV-RGX-314 vs CKD-701 · ABBV-RGX-314 vs HLX04-O · ABBV-RGX-314 vs KSI-301 · ABBV-RGX-314 vs MW02